首页 > 最新文献

Roczniki Akademii Medycznej w Bialymstoku (1995)最新文献

英文 中文
Changes of beta2-adrenergic stimulation induced by hyperosmosis in human atrium. 高渗诱导心房β -肾上腺素能刺激的变化。
D Zablockaite, V Gendviliene, R Macianskiene, V A Skeberdis, J Jurevicius, G Kanaporis, R Benetis

Purpose: The purpose of the present study was to determine whether extracellular osmotic pressure modulates beta2-adrenergic stimulation of the contraction force and L-type Ca2+ current in human atrial myocytes.

Material and methods: Experiments were performed on human atrial trabeculae and myocytes isolated from the right atrium. The concentration dependent effect of salbutamol (SAL), a beta2-adrenoreceptor agonist, on peak tension (P) and L-type calcium current (ICaL) under isoosmolar (345 mOsm) and hyperosmolar (405 or 525 mOsm was achieved by adding of mannitol) conditions was studied.

Results: Salbutamol (10 nmol/L-10 micromol/L) added to the control solution increased P by 180.6 +/- 45.8% over control with a half-stimulation constant EC50 = 27 +/- 6 nmol/L. Under isoosmolar conditions SAL (0.1/10(3)nmol/L) increased ICaL by 182.3 +/- 19.8% over control with an EC50 2.9 +/- 0.9 nmol/L. In hyperosmolar solutions the same concentrations of SAL increased P and ICaL by 57.2 +/- 12.6% and 217.2 +/- 70.5% over control with EC50 = 640 +/- 260 nmol/L and 12 +/- 5 nmol/L respectively.

Conclusions: These results indicated that hyperosmolarity reduced the effect of beta2-adrenergic stimulation, i.e. the dose-response curve of salbutamol on L-type calcium current was shifted to the higher concentration range and maximal increase in contraction force was diminished in human atrial cells.

目的:本研究的目的是确定细胞外渗透压是否调节β -肾上腺素能刺激心房肌细胞收缩力和l型Ca2+电流。材料和方法:以人心房小梁和右心房肌细胞为实验材料。研究了β -肾上腺素受体激动剂沙丁胺醇(SAL)在等渗(345 mOsm)和高渗(添加甘露醇达到405或525 mOsm)条件下对峰值张力(P)和l型钙电流(ICaL)的浓度依赖性。结果:对照液中添加10 nmol/L-10微mol/L的沙丁胺醇使P值比对照提高180.6 +/- 45.8%,半刺激常数EC50 = 27 +/- 6 nmol/L。在等摩尔条件下,SAL (0.1/10(3)nmol/L)比对照提高了182.3 +/- 19.8%,EC50为2.9 +/- 0.9 nmol/L。在高渗溶液中,当EC50 = 640 +/- 260 nmol/L和12 +/- 5 nmol/L时,相同浓度的SAL使P和ICaL分别比对照增加了57.2 +/- 12.6%和217.2 +/- 70.5%。结论:高渗透压降低了β -肾上腺素能刺激的作用,即沙丁胺醇对心房细胞l型钙电流的量效曲线向较高浓度范围偏移,收缩力的最大增幅减弱。
{"title":"Changes of beta2-adrenergic stimulation induced by hyperosmosis in human atrium.","authors":"D Zablockaite,&nbsp;V Gendviliene,&nbsp;R Macianskiene,&nbsp;V A Skeberdis,&nbsp;J Jurevicius,&nbsp;G Kanaporis,&nbsp;R Benetis","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the present study was to determine whether extracellular osmotic pressure modulates beta2-adrenergic stimulation of the contraction force and L-type Ca2+ current in human atrial myocytes.</p><p><strong>Material and methods: </strong>Experiments were performed on human atrial trabeculae and myocytes isolated from the right atrium. The concentration dependent effect of salbutamol (SAL), a beta2-adrenoreceptor agonist, on peak tension (P) and L-type calcium current (ICaL) under isoosmolar (345 mOsm) and hyperosmolar (405 or 525 mOsm was achieved by adding of mannitol) conditions was studied.</p><p><strong>Results: </strong>Salbutamol (10 nmol/L-10 micromol/L) added to the control solution increased P by 180.6 +/- 45.8% over control with a half-stimulation constant EC50 = 27 +/- 6 nmol/L. Under isoosmolar conditions SAL (0.1/10(3)nmol/L) increased ICaL by 182.3 +/- 19.8% over control with an EC50 2.9 +/- 0.9 nmol/L. In hyperosmolar solutions the same concentrations of SAL increased P and ICaL by 57.2 +/- 12.6% and 217.2 +/- 70.5% over control with EC50 = 640 +/- 260 nmol/L and 12 +/- 5 nmol/L respectively.</p><p><strong>Conclusions: </strong>These results indicated that hyperosmolarity reduced the effect of beta2-adrenergic stimulation, i.e. the dose-response curve of salbutamol on L-type calcium current was shifted to the higher concentration range and maximal increase in contraction force was diminished in human atrial cells.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"244-6"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children. 儿童抗白血病治疗期间胰岛素样生长因子(IGF-I和IGF-II)、igf结合蛋白(IGFBP-3、IGFBP-2)、瘦素与人体测量参数(身高、体重指数)的关系
M Krawczuk-Rybak, K Muszyńska-Rosłan, A Kitszel, M Sawicka-Zukowska, S Wołczyński

Purpose: The aim of the study was to estimate the anthropometric parameters and their relationship to serum levels of IGF-I, IGF-II, IGFBP-3, IGFBP-2 and leptin before and during intensive antineoplastic treatment for acute lymphoblastic leukaemia in children.

Material and methods: In 46 children in median age 6.6 years (range from 1.6 to 16) we evaluated at the time of diagnosis, after protocol I and after intensive treatment, height, body mass index (BMI) and IGF-I, IGF-II, IGFBP-3, IGFBP-2 and leptin.

Results: Height SDS lowered in successive points of analysis whereas BMI SDS rose after protocol II. IGF-I SDS was low and similar at each point, IGF-II SDS and IGFBP-3 SDS values augmented progressively and IGFBP-2 SDS was significantly elevated before treatment and lowered (but not normalized) during the therapy. Leptin SDS was elevated, especially after protocol I.

Conclusion: Leukaemia and its treatment affect directly growth factors, its binding proteins and leptin production leading to growth retardation and overweight.

目的:本研究的目的是评估儿童急性淋巴细胞白血病强化抗肿瘤治疗前和期间的人体测量参数及其与血清IGF-I、IGF-II、IGFBP-3、IGFBP-2和瘦素水平的关系。材料和方法:我们对46名中位年龄6.6岁(范围从1.6岁到16岁)的儿童在诊断时、方案I后和强化治疗后的身高、体重指数(BMI)和IGF-I、IGF-II、IGFBP-3、IGFBP-2和瘦素进行了评估。结果:身高SDS在连续分析点下降,而BMI SDS在方案II后上升。IGF-I SDS在每个点都很低且相似,IGF-II SDS和IGFBP-3 SDS值逐渐增加,IGFBP-2 SDS在治疗前显著升高,在治疗期间显著降低(但未正常化)。结论:白血病及其治疗直接影响生长因子、其结合蛋白和瘦素的产生,导致生长迟缓和超重。
{"title":"Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children.","authors":"M Krawczuk-Rybak,&nbsp;K Muszyńska-Rosłan,&nbsp;A Kitszel,&nbsp;M Sawicka-Zukowska,&nbsp;S Wołczyński","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of the study was to estimate the anthropometric parameters and their relationship to serum levels of IGF-I, IGF-II, IGFBP-3, IGFBP-2 and leptin before and during intensive antineoplastic treatment for acute lymphoblastic leukaemia in children.</p><p><strong>Material and methods: </strong>In 46 children in median age 6.6 years (range from 1.6 to 16) we evaluated at the time of diagnosis, after protocol I and after intensive treatment, height, body mass index (BMI) and IGF-I, IGF-II, IGFBP-3, IGFBP-2 and leptin.</p><p><strong>Results: </strong>Height SDS lowered in successive points of analysis whereas BMI SDS rose after protocol II. IGF-I SDS was low and similar at each point, IGF-II SDS and IGFBP-3 SDS values augmented progressively and IGFBP-2 SDS was significantly elevated before treatment and lowered (but not normalized) during the therapy. Leptin SDS was elevated, especially after protocol I.</p><p><strong>Conclusion: </strong>Leukaemia and its treatment affect directly growth factors, its binding proteins and leptin production leading to growth retardation and overweight.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"208-11"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical treatment of congestive heart failure in coronary artery disease. 冠状动脉疾病致充血性心力衰竭的外科治疗。
R Benetis

Heart failure (HF) is a pathophysiological condition, when the heart can not provide adequate blood flow to the body organs. The main cause of HF is now ischemic heart disease (IHD), and the number of patients with HF in aging society is growing. HF is becoming the leading cause of death. Medical therapy does not provide satisfactory results in respect of symptoms and survival (5 year survival 28-40%). Therefore there is a trend towards early invasive methods of IHD treatment: percutaneous or surgical revascularisation and surgical reconstruction of myocardial damage. Most common surgical procedure in IHD is coronary artery bypass grafting (CABG). This treatment is safe and effective in patients with normal ventricular function (operative mortality 0.5%, 5 year survival >92%). Results in patients with impaired left ventricular (LV) function are better than conservative therapy, but still not satisfactory (operative mortality 8.4%, 5 year survival 65%). The modern surgical concept for improvement of ventricular function is left ventricular (LV) shape and volume restoration (SVR) accompanied by CABG. In cases of severe damage of myocardium resulting in left ventricular aneurysm or akinesia, SVR improves LV function and prevents further LV remodeling. At present it is under investigation whether SVR is of benefit for moderate-sized ventricles and NYHA class II symptoms. In case of ischemic mitral insufficiency mitral valve repair is a method of choice. The results of combined procedures in Heart Failure group (CABG + MV reconstruction or SVR) are better than CABG alone. Other surgical alternatives for HF treatment are: heart transplantation, ventricular assist devices (VAD), dynamic cardiomyoplasty, constrictive devices and cellular transplantation therapy. Heart transplantation is reserved for younger patients with less comorbidities. Shortage of donor organs and poor long-term results remains a main problem of such a treatment. VAD at present is still very expensive, and serves particularly as a "bridge to heart transplantation" or "bridge to recovery" rather than destination therapy. Despite of all achievements in medical or invasive HF treatment further basic and clinical works as well as new organization systems are necessary to find optimal strategies to reduce cost of care, improve quality of life and survival.

心力衰竭(HF)是一种病理生理状况,当心脏不能提供足够的血液流向身体器官。目前,心衰的主要病因是缺血性心脏病(IHD),在老龄化社会中,心衰患者人数不断增加。心衰正在成为导致死亡的主要原因。药物治疗在症状和生存率(5年生存率28-40%)方面不能提供令人满意的结果。因此,有一种倾向于早期侵入性治疗IHD的方法:经皮或手术血运重建术和心肌损伤的手术重建。IHD最常见的外科手术是冠状动脉旁路移植术(CABG)。这种治疗对于心室功能正常的患者是安全有效的(手术死亡率0.5%,5年生存率>92%)。结果左心室功能受损患者优于保守治疗,但仍不令人满意(手术死亡率8.4%,5年生存率65%)。改善心室功能的现代外科理念是左室(LV)形状和容量恢复(SVR)伴行CABG。在心肌严重损伤导致左室动脉瘤或运动障碍的情况下,SVR可改善左室功能,防止左室进一步重构。目前正在研究SVR是否对中等大小心室和NYHA II类症状有益。在缺血性二尖瓣功能不全的情况下,二尖瓣修复是一种选择。心衰组联合手术(CABG + MV重建或SVR)的效果优于单独CABG。心衰治疗的其他手术选择有:心脏移植、心室辅助装置(VAD)、动态心肌成形术、收缩装置和细胞移植治疗。心脏移植只适用于合并症较少的年轻患者。供体器官短缺和长期效果不佳仍然是这种治疗的主要问题。VAD目前仍然非常昂贵,特别是作为“心脏移植的桥梁”或“康复的桥梁”,而不是最终治疗。尽管在医疗或侵入性心衰治疗方面取得了诸多成就,但仍需要进一步的基础和临床工作以及新的组织体系来寻找降低护理成本、提高生活质量和生存率的最佳策略。
{"title":"Surgical treatment of congestive heart failure in coronary artery disease.","authors":"R Benetis","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Heart failure (HF) is a pathophysiological condition, when the heart can not provide adequate blood flow to the body organs. The main cause of HF is now ischemic heart disease (IHD), and the number of patients with HF in aging society is growing. HF is becoming the leading cause of death. Medical therapy does not provide satisfactory results in respect of symptoms and survival (5 year survival 28-40%). Therefore there is a trend towards early invasive methods of IHD treatment: percutaneous or surgical revascularisation and surgical reconstruction of myocardial damage. Most common surgical procedure in IHD is coronary artery bypass grafting (CABG). This treatment is safe and effective in patients with normal ventricular function (operative mortality 0.5%, 5 year survival >92%). Results in patients with impaired left ventricular (LV) function are better than conservative therapy, but still not satisfactory (operative mortality 8.4%, 5 year survival 65%). The modern surgical concept for improvement of ventricular function is left ventricular (LV) shape and volume restoration (SVR) accompanied by CABG. In cases of severe damage of myocardium resulting in left ventricular aneurysm or akinesia, SVR improves LV function and prevents further LV remodeling. At present it is under investigation whether SVR is of benefit for moderate-sized ventricles and NYHA class II symptoms. In case of ischemic mitral insufficiency mitral valve repair is a method of choice. The results of combined procedures in Heart Failure group (CABG + MV reconstruction or SVR) are better than CABG alone. Other surgical alternatives for HF treatment are: heart transplantation, ventricular assist devices (VAD), dynamic cardiomyoplasty, constrictive devices and cellular transplantation therapy. Heart transplantation is reserved for younger patients with less comorbidities. Shortage of donor organs and poor long-term results remains a main problem of such a treatment. VAD at present is still very expensive, and serves particularly as a \"bridge to heart transplantation\" or \"bridge to recovery\" rather than destination therapy. Despite of all achievements in medical or invasive HF treatment further basic and clinical works as well as new organization systems are necessary to find optimal strategies to reduce cost of care, improve quality of life and survival.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"45-9"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes of lysosomal enzymes activity in the skeletal muscle fibers exposed to endurance exercise. 耐力运动对骨骼肌纤维溶酶体酶活性的影响。
E Bakońska-Pacoń, Z Jethon, M Podhorska-Okołów, P Dziegiel

Purpose: To evaluate the effect of endurance exercise on the activity changes of selected lysosomal enzymes in particular types of rat muscle fibers, occurring by 0-4 days following the trial.

Material and methods: The experiment was performed on 3 month old male Wistar rats with body mass 250 +/- 25 g, exposed to single physical exercise on moving track (speed 17 m x min(-1), decline 0 degree, duration 87.5 +/- 27.5 min). Biochemical analyses were performed on homogenized fast-twitch FTa and FTb (m. gastrocnemius) and slow-twitch ST (m. soleus) muscle fibers of animals sacrificed 2 h (group II), 6 h (III) or 96 h (IV) after exercise and control group. The measurements considered protein concentration and the activities of beta-glucuronidase (beta-GRS), N-acetyl-beta-D-glucosaminidase (NAG), and arylsulphatase A (ASA).

Results: In FTa fibers, ASA and beta-GRS activities were elevated in all the exercised groups, with the most evident changes in animals tested 96 h post trial (group IV), while the peak of NAG activity was demonstrated 2 h after exercise (group II). In contrast, in FTb and ST fibers the levels of all the enzymes studied peaked 96 h after exercise, following the transient decrease in activity.

Conclusions: The present study demonstrated that maximal running exercise, without the eccentric components, affects the activities of lysosomal enzymes in all types of rat muscular fibers. The lack of uniform activity profile for the lysosomal enzymes studied probably reflects the variety of their cellular functions.

目的:评价耐力运动对大鼠特定类型肌纤维中选定溶酶体酶活性变化的影响,这种变化发生在试验后0-4天。材料与方法:3月龄雄性Wistar大鼠,体质量250 +/- 25 g,在运动轨道上进行单次运动(速度17 m × min(-1),下降0度,持续时间87.5 +/- 27.5 min)。分别在运动后2 h (II组)、6 h (III组)、96 h (IV组)和对照组处死动物,对匀浆后的快肌纤维FTa、FTb(腓肠肌)和慢肌纤维ST(比目鱼肌)进行生化分析。测量考虑了蛋白质浓度和β -葡萄糖苷酶(β - grs)、n -乙酰- β - d -葡萄糖苷酶(NAG)和芳基硫酸酶A (ASA)的活性。结果:在自由贸易区纤维中,ASA和β - grs活性在所有运动组中都有所升高,其中以试验后96 h (IV组)的变化最为明显,而NAG活性在运动后2 h达到峰值(II组)。相反,在FTb和ST纤维中,所有酶的水平在运动后96 h达到峰值,之后活性短暂下降。结论:本研究表明,最大限度的跑步运动,不偏心成分,影响所有类型的大鼠肌纤维溶酶体酶的活性。所研究的溶酶体酶缺乏统一的活性谱可能反映了它们细胞功能的多样性。
{"title":"Changes of lysosomal enzymes activity in the skeletal muscle fibers exposed to endurance exercise.","authors":"E Bakońska-Pacoń,&nbsp;Z Jethon,&nbsp;M Podhorska-Okołów,&nbsp;P Dziegiel","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effect of endurance exercise on the activity changes of selected lysosomal enzymes in particular types of rat muscle fibers, occurring by 0-4 days following the trial.</p><p><strong>Material and methods: </strong>The experiment was performed on 3 month old male Wistar rats with body mass 250 +/- 25 g, exposed to single physical exercise on moving track (speed 17 m x min(-1), decline 0 degree, duration 87.5 +/- 27.5 min). Biochemical analyses were performed on homogenized fast-twitch FTa and FTb (m. gastrocnemius) and slow-twitch ST (m. soleus) muscle fibers of animals sacrificed 2 h (group II), 6 h (III) or 96 h (IV) after exercise and control group. The measurements considered protein concentration and the activities of beta-glucuronidase (beta-GRS), N-acetyl-beta-D-glucosaminidase (NAG), and arylsulphatase A (ASA).</p><p><strong>Results: </strong>In FTa fibers, ASA and beta-GRS activities were elevated in all the exercised groups, with the most evident changes in animals tested 96 h post trial (group IV), while the peak of NAG activity was demonstrated 2 h after exercise (group II). In contrast, in FTb and ST fibers the levels of all the enzymes studied peaked 96 h after exercise, following the transient decrease in activity.</p><p><strong>Conclusions: </strong>The present study demonstrated that maximal running exercise, without the eccentric components, affects the activities of lysosomal enzymes in all types of rat muscular fibers. The lack of uniform activity profile for the lysosomal enzymes studied probably reflects the variety of their cellular functions.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 Suppl 1 ","pages":"284-7"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25264663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helicobacter pylori eradication as prevention against chronic peptic ulcer disease in children. 根除幽门螺杆菌预防儿童慢性消化性溃疡。
E Maciorkowska, M Kaczmarski, J Skowrońska, J M Cieśla, U Chrzanowska, B T Olejnik, A Sacharewicz, E Ryszczuk

The changes caused by Helicobacter pylori are a slow, progressing inflammatory process developing from several to dozen years. H. pylori infection leads to an inflammatory response in the gastric mucosa with granulocyte infiltrates in an acute form of the inflammation, and lymphocytes, plasmatic, macrophages and eosinophils in a chronic form inducing the development of gastric and duodenal ulcers and gastric cancer in some patients. The frequency and the type of morphological changes in the gastric mucosa were analyzed in children with positive IgG against H. pylori and the incidence of gastric and duodenal ulcers in family members of children examined was evaluated in our study. Gastritis was reported in 68.8% of children with positive IgG against H. pylori. Gastric ulcer was confirmed in 37.1% of families of children included in the study. Duodenal ulcers were found in 22.9% of families. The results obtained, indicate the usefulness of long-term observation and clinical follow-up of children with chronic gastritis of H. pylori ethiology taking into consideration bacterium eradication as prophylaxis of peptic ulceration.

幽门螺杆菌引起的变化是一个缓慢的,渐进的炎症过程,持续数年至数十年。幽门螺杆菌感染可引起胃粘膜炎症反应,急性炎症形式为粒细胞浸润,慢性炎症形式为淋巴细胞、浆细胞、巨噬细胞和嗜酸性粒细胞浸润,部分患者可诱发胃和十二指肠溃疡和胃癌。分析了幽门螺杆菌IgG抗体阳性儿童胃黏膜形态改变的频率和类型,并评估了所检查儿童家庭成员胃溃疡和十二指肠溃疡的发生率。幽门螺杆菌IgG阳性儿童胃炎发生率为68.8%。研究中有37.1%的儿童家庭确诊胃溃疡。22.9%的家庭存在十二指肠溃疡。结果表明,长期观察和临床随访儿童慢性胃炎幽门螺杆菌伦理学考虑根除细菌作为预防消化性溃疡的有效性。
{"title":"Helicobacter pylori eradication as prevention against chronic peptic ulcer disease in children.","authors":"E Maciorkowska,&nbsp;M Kaczmarski,&nbsp;J Skowrońska,&nbsp;J M Cieśla,&nbsp;U Chrzanowska,&nbsp;B T Olejnik,&nbsp;A Sacharewicz,&nbsp;E Ryszczuk","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The changes caused by Helicobacter pylori are a slow, progressing inflammatory process developing from several to dozen years. H. pylori infection leads to an inflammatory response in the gastric mucosa with granulocyte infiltrates in an acute form of the inflammation, and lymphocytes, plasmatic, macrophages and eosinophils in a chronic form inducing the development of gastric and duodenal ulcers and gastric cancer in some patients. The frequency and the type of morphological changes in the gastric mucosa were analyzed in children with positive IgG against H. pylori and the incidence of gastric and duodenal ulcers in family members of children examined was evaluated in our study. Gastritis was reported in 68.8% of children with positive IgG against H. pylori. Gastric ulcer was confirmed in 37.1% of families of children included in the study. Duodenal ulcers were found in 22.9% of families. The results obtained, indicate the usefulness of long-term observation and clinical follow-up of children with chronic gastritis of H. pylori ethiology taking into consideration bacterium eradication as prophylaxis of peptic ulceration.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 Suppl 1 ","pages":"137-40"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25266178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic treatment in acute pancreatitis. 急性胰腺炎的抗生素治疗。
G Uomo

Severe acute pancreatitis is characterized by a poor prognosis with local and systemic complications, high morbidity and mortality. From the morphological standpoint, almost all patients suffering from severe forms of acute pancreatitis present various degree of pancreatic necrosis. In these patients the occurrence of infection of pancreatic necrosis certainly represents a very important prognostic factor as it has worldwide accepted as the leading cause of death. In addition, the discovery of an infected necrosis represents a crucial point in the treatment of these patients as it is the only clear-cut shift from medical to surgical treatment in necrotizing pancreatitis. Over the last years, earlier and more precise identification of pancreatic necrosis together with availability of new classes of antibiotics with documented activity against the most commonly involved bacteria and able to reach in therapeutic concentration the pancreatic necrosis give us the opportunity to perform some important controlled clinical trials on antibiotic prophylaxis in necrotizing acute pancreatitis. The great majority of these studies showed the usefulness of a prophylactic regimen (using antibiotics such as fluoroquinolones and carbapenems) in terms of reduction of pancreatic and extrapancreatic infections in comparison with untreated controls. Nevertheless, some questions on this topic still present controversial aspects such as the antibiotic of choice, the duration of treatment, the possible opportunistic infections with fungi and/or resistant strains. Antibiotics may prove very useful in patients with documented infected necrosis and high anaesthesiological risk unfit for surgical debridement and drainage; some initial experiences show the possibility that antibiotic treatment may be curative without surgery in these selected cases.

严重急性胰腺炎的特点是预后差,伴有局部和全身并发症,发病率和死亡率高。从形态学角度来看,几乎所有重症急性胰腺炎患者都表现出不同程度的胰腺坏死。在这些患者中,胰腺坏死感染的发生无疑是一个非常重要的预后因素,因为它已被全世界公认为死亡的主要原因。此外,感染坏死的发现是治疗这些患者的一个关键点,因为它是坏死性胰腺炎从药物治疗到手术治疗的唯一明确转变。在过去的几年里,胰腺坏死的早期和更精确的识别,以及新型抗生素的可用性,这些抗生素对最常见的细菌具有活性,并且能够达到治疗胰腺坏死的浓度,这使我们有机会在坏死性急性胰腺炎的抗生素预防方面进行一些重要的对照临床试验。这些研究中的绝大多数表明,与未经治疗的对照组相比,预防性方案(使用氟喹诺酮类和碳青霉烯类等抗生素)在减少胰腺和胰腺外感染方面是有用的。然而,关于这一主题的一些问题仍然存在争议,如抗生素的选择,治疗的持续时间,真菌和/或耐药菌株可能的机会性感染。抗生素可能被证明是非常有用的患者感染坏死和高麻醉风险不适合手术清创和引流;一些初步经验表明,在这些选定的病例中,抗生素治疗可能无需手术即可治愈。
{"title":"Antibiotic treatment in acute pancreatitis.","authors":"G Uomo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Severe acute pancreatitis is characterized by a poor prognosis with local and systemic complications, high morbidity and mortality. From the morphological standpoint, almost all patients suffering from severe forms of acute pancreatitis present various degree of pancreatic necrosis. In these patients the occurrence of infection of pancreatic necrosis certainly represents a very important prognostic factor as it has worldwide accepted as the leading cause of death. In addition, the discovery of an infected necrosis represents a crucial point in the treatment of these patients as it is the only clear-cut shift from medical to surgical treatment in necrotizing pancreatitis. Over the last years, earlier and more precise identification of pancreatic necrosis together with availability of new classes of antibiotics with documented activity against the most commonly involved bacteria and able to reach in therapeutic concentration the pancreatic necrosis give us the opportunity to perform some important controlled clinical trials on antibiotic prophylaxis in necrotizing acute pancreatitis. The great majority of these studies showed the usefulness of a prophylactic regimen (using antibiotics such as fluoroquinolones and carbapenems) in terms of reduction of pancreatic and extrapancreatic infections in comparison with untreated controls. Nevertheless, some questions on this topic still present controversial aspects such as the antibiotic of choice, the duration of treatment, the possible opportunistic infections with fungi and/or resistant strains. Antibiotics may prove very useful in patients with documented infected necrosis and high anaesthesiological risk unfit for surgical debridement and drainage; some initial experiences show the possibility that antibiotic treatment may be curative without surgery in these selected cases.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"116-21"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric juice ammonia and urea concentrations and their relation to gastric mucosa injury in patients maintained on chronic hemodialysis. 慢性血液透析患者胃液氨、尿素浓度及其与胃黏膜损伤的关系
K Blusiewicz, G Rydzewska, A Rydzewski

Purpose: This study was undertaken to test the hypothesis that high concentrations of urea in gastric juice would have an influence on Helicobacter pylori infection in patients maintained on chronic hemodialysis (HD).

Material and methods: We investigated 30 patients (17 males, 13 females; mean age 50.8 +/- 2.9 years) with end-stage renal disease (ESRD) undergoing hemodialysis treatment (HD) for at least 6 months, who were compared to 31 patients (16 males, 15 females; mean age 61.3 +/- 2.2 years) with dyspeptic symptoms. Biopsies from the gastric antrum and body were taken for histological investigation. Urea and ammonia were measured in gastric juice, and the severity of gastritis was evaluated according to Sydney criteria.

Results: H. pylori infection was found in 19 (63%) HD patients and in 22 (71%) control subjects. Gastric juice urea concentration was significantly higher in HD patients than in controls and H. pylori infection caused a significant decrease in urea concentration in both groups. There was an inverse correlation between urea and ammonia concentration in gastric juice in both groups. Ammonia concentration in both groups was higher in H. pylori infected patients. In H. pylori negative subjects ammonia/urea ratio was lower in HD patients in comparison to controls. Ammonia/urea ratio was raised by H. pylori infection in both groups, and the difference between HD and control groups persisted. H. pylori infection was associated with polymorphonuclear infiltration of gastric mucosa. There was a significant correlation between gastric ammonia and mucosal polymorphonuclear leukocytes infiltration and gastritis score.

Conclusions: Higher urea levels in the gastric juice of chronically hemodialyzed patients do not seem to be a risk factor for infection with Helicobacter pylori.

目的:本研究旨在验证胃液高浓度尿素对慢性血液透析患者幽门螺杆菌感染的影响。材料与方法:我们调查了30例患者,其中男性17例,女性13例;接受血液透析治疗(HD)至少6个月的终末期肾病(ESRD)患者(平均年龄50.8±2.9岁),与31例患者(16名男性,15名女性;平均年龄61.3±2.2岁,有消化不良症状。取胃窦及胃体活检作组织学检查。测定胃液中尿素和氨含量,按照悉尼标准评价胃炎的严重程度。结果:HD患者幽门螺杆菌感染19例(63%),对照组22例(71%)。HD患者胃液尿素浓度显著高于对照组,幽门螺旋杆菌感染导致两组患者胃液尿素浓度显著降低。两组大鼠胃液中尿素、氨浓度呈负相关。两组幽门螺杆菌感染患者氨浓度均较高。在幽门螺杆菌阴性受试者中,HD患者的氨/尿素比低于对照组。两组的氨尿素比均因幽门螺旋杆菌感染而升高,且与对照组的差异持续存在。幽门螺杆菌感染与胃粘膜多形核浸润有关。胃氨氮与黏膜多形核白细胞浸润与胃炎评分有显著相关性。结论:慢性血液透析患者胃液中较高的尿素水平似乎不是幽门螺杆菌感染的危险因素。
{"title":"Gastric juice ammonia and urea concentrations and their relation to gastric mucosa injury in patients maintained on chronic hemodialysis.","authors":"K Blusiewicz,&nbsp;G Rydzewska,&nbsp;A Rydzewski","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>This study was undertaken to test the hypothesis that high concentrations of urea in gastric juice would have an influence on Helicobacter pylori infection in patients maintained on chronic hemodialysis (HD).</p><p><strong>Material and methods: </strong>We investigated 30 patients (17 males, 13 females; mean age 50.8 +/- 2.9 years) with end-stage renal disease (ESRD) undergoing hemodialysis treatment (HD) for at least 6 months, who were compared to 31 patients (16 males, 15 females; mean age 61.3 +/- 2.2 years) with dyspeptic symptoms. Biopsies from the gastric antrum and body were taken for histological investigation. Urea and ammonia were measured in gastric juice, and the severity of gastritis was evaluated according to Sydney criteria.</p><p><strong>Results: </strong>H. pylori infection was found in 19 (63%) HD patients and in 22 (71%) control subjects. Gastric juice urea concentration was significantly higher in HD patients than in controls and H. pylori infection caused a significant decrease in urea concentration in both groups. There was an inverse correlation between urea and ammonia concentration in gastric juice in both groups. Ammonia concentration in both groups was higher in H. pylori infected patients. In H. pylori negative subjects ammonia/urea ratio was lower in HD patients in comparison to controls. Ammonia/urea ratio was raised by H. pylori infection in both groups, and the difference between HD and control groups persisted. H. pylori infection was associated with polymorphonuclear infiltration of gastric mucosa. There was a significant correlation between gastric ammonia and mucosal polymorphonuclear leukocytes infiltration and gastritis score.</p><p><strong>Conclusions: </strong>Higher urea levels in the gastric juice of chronically hemodialyzed patients do not seem to be a risk factor for infection with Helicobacter pylori.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"188-92"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation. 过氧化物酶体增殖体激活受体γ配体通过调节nf - kappab依赖的促炎细胞因子的产生和胰腺星状细胞的激活来预防慢性胰腺炎的发展。
S Hisada, K Shimizu, K Shiratori, M Kobayashi

Purpose: Thiazolidinedione derivatives (TZDs) are known to be ligands of peroxisome proliferator-activated receptor gamma (PPARgamma). In this study, we investigated the effect of a TZD, troglitazone, on inflammation and fibrogenesis in the pancreas of an experimental model of chronic pancreatitis.

Material and methods: Male WBN/Kob rats with spontaneous chronic pancreatitis were fed rat chow containing 0.2% troglitazone from 1 to 4 months of age. Immunohistochemical studies of rat pancreas were carried out with monoclonal mouse antibody against human alpha-smooth muscle actin (alpha-SMA) or rabbit polyclonal antibody against collagen type I, collagen type III, or fibronectin. Cytokine production was measured by enzyme-linked immunosorbent assay. The inhibitory action of troglitazone on nuclear factor-kappaB (NF-kappaB) binding activity in activated macrophages was also investigated.

Results: Long-term administration of troglitazone reduced inflammatory cell infiltration and fibrosis in the pancreas of WBN/Kob rats, and expression of alpha-SMA, procollagen I, III, and fibronectin was significantly reduced by troglitazone. The increase in TNF-alpha production by activated macrophages was significantly decreased by troglitazone. Peritoneal macrophages isolated from WBN/Kob rats produced a large amount of TNF-alpha, whereas those from troglitazone-treated WBN/Kob rats produced only a marginal amount of TNF-alpha. Lipopolysaccharide-induced NF-kappaB binding activity in peritoneal macrophages was also significantly reduced by troglitazone.

Conclusions: Troglitazone prevented the progression of chronic pancreatitis via inhibition of ECM synthesis and proinflammatory cytokine production mediated by the inhibition of NF-kappaB activity.

目的:噻唑烷二酮衍生物(TZDs)是已知的过氧化物酶体增殖物激活受体(pppargamma)的配体。在这项研究中,我们研究了一种TZD,曲格列酮,对慢性胰腺炎实验模型胰腺炎症和纤维生成的影响。材料与方法:自发性慢性胰腺炎雄性WBN/Kob大鼠1 ~ 4月龄饲喂含有0.2%曲格列酮的大鼠饲料。采用小鼠抗人α -平滑肌肌动蛋白(α - sma)单克隆抗体或兔抗I型胶原、III型胶原或纤维连接蛋白多克隆抗体对大鼠胰腺进行免疫组化研究。采用酶联免疫吸附法测定细胞因子的产生。研究了曲格列酮对活化巨噬细胞核因子κ b (nf - κ b)结合活性的抑制作用。结果:长期服用曲格列酮可减少WBN/Kob大鼠胰腺炎症细胞浸润和纤维化,显著降低α - sma、前胶原I、III和纤维连接蛋白的表达。激活的巨噬细胞产生tnf - α的增加被曲格列酮显著降低。从WBN/Kob大鼠分离的腹腔巨噬细胞产生大量的tnf - α,而从罗格列酮处理的WBN/Kob大鼠分离的巨噬细胞仅产生少量的tnf - α。脂多糖诱导的nf - κ b在腹腔巨噬细胞中的结合活性也被曲格列酮显著降低。结论:曲格列酮通过抑制NF-kappaB活性介导的ECM合成和促炎细胞因子的产生来预防慢性胰腺炎的进展。
{"title":"Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation.","authors":"S Hisada,&nbsp;K Shimizu,&nbsp;K Shiratori,&nbsp;M Kobayashi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Thiazolidinedione derivatives (TZDs) are known to be ligands of peroxisome proliferator-activated receptor gamma (PPARgamma). In this study, we investigated the effect of a TZD, troglitazone, on inflammation and fibrogenesis in the pancreas of an experimental model of chronic pancreatitis.</p><p><strong>Material and methods: </strong>Male WBN/Kob rats with spontaneous chronic pancreatitis were fed rat chow containing 0.2% troglitazone from 1 to 4 months of age. Immunohistochemical studies of rat pancreas were carried out with monoclonal mouse antibody against human alpha-smooth muscle actin (alpha-SMA) or rabbit polyclonal antibody against collagen type I, collagen type III, or fibronectin. Cytokine production was measured by enzyme-linked immunosorbent assay. The inhibitory action of troglitazone on nuclear factor-kappaB (NF-kappaB) binding activity in activated macrophages was also investigated.</p><p><strong>Results: </strong>Long-term administration of troglitazone reduced inflammatory cell infiltration and fibrosis in the pancreas of WBN/Kob rats, and expression of alpha-SMA, procollagen I, III, and fibronectin was significantly reduced by troglitazone. The increase in TNF-alpha production by activated macrophages was significantly decreased by troglitazone. Peritoneal macrophages isolated from WBN/Kob rats produced a large amount of TNF-alpha, whereas those from troglitazone-treated WBN/Kob rats produced only a marginal amount of TNF-alpha. Lipopolysaccharide-induced NF-kappaB binding activity in peritoneal macrophages was also significantly reduced by troglitazone.</p><p><strong>Conclusions: </strong>Troglitazone prevented the progression of chronic pancreatitis via inhibition of ECM synthesis and proinflammatory cytokine production mediated by the inhibition of NF-kappaB activity.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"142-7"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single Nucleotide Polymorphisms in exon 3 of the adiponectin gene in subjects with type 2 diabetes mellitus. 2型糖尿病患者脂联素基因外显子3的单核苷酸多态性
A Kretowski, K Gugała, A Okruszko, N Wawrusiewicz-Kurylonek, M Górska

Purpose: Adiponectin (APM1)--a newly discovered adipocytokine secreted by fat tissue--was recently suggested to play a role in the genetic predisposition to type 2 diabetes, obesity and insulin resistance. Adiponectin gene is localized on chromosome 3q27 within the region which was identified as susceptibility locus for type 2 diabetes and metabolic syndrome. Till now genetic associations of two SNP in exon 2 (+45T/G) and intron 2 (+276G/T) of adiponectin gene with type 2 diabetes and adiponectin level were reported in Japanese population and with insulin resistance in some Caucasian populations (Italy, Germany). Moreover, in the proximal promoter region of the APM1 gene: SNP-11426A/G and -11391A/-11377G haplotype predicted the associations with fasting plasma glucose, type 2 diabetes and adiponectin levels. On the other hand the role of mutations in exon 3 of the adiponectin gene is not so well studied.

Material and methods: The aim of our study was the screening for rare mutation in exon 3 of adiponectin gene in the Polish subjects with type 2 diabetes as there is no data available about the frequency and role of these mutations in our population. The study was performed in the group of 187 Polish origin patients with type 2 diabetes (32 female and 155 male, mean age 54.1 +/- 8.6 yrs) and 102 age and sex matched healthy controls.

Results: The frequency of adiponectin gene mutations in exon 3 was 3.9%, while in the control group 0.98% and this difference was not statistically significant. We also observed that adiponectin level is significantly lower in patients with c.331 T-->C mutation (Y111H) in comparison to subjects without this mutation (5.0 ug/ml vs 14.4 ug/ml, p=0.0148).

Conclusions: To our knowledge the present study is the first which shows that in Polish populations.

目的:脂联素(APM1)是一种由脂肪组织分泌的新发现的脂肪细胞因子,最近被认为在2型糖尿病、肥胖和胰岛素抵抗的遗传易感性中发挥作用。脂联素基因定位在2型糖尿病和代谢综合征易感位点的3q27染色体上。迄今为止,有报道称脂联素基因外显子2 (+45T/G)和内含子2 (+276G/T)的两个SNP与2型糖尿病和脂联素水平有关,在日本人群和一些高加索人群(意大利、德国)中与胰岛素抵抗有关。此外,在APM1基因的近端启动子区域:SNP-11426A/G和-11391A/-11377G单倍型预测与空腹血糖、2型糖尿病和脂联素水平的关联。另一方面,脂联素基因外显子3突变的作用还没有得到很好的研究。材料和方法:我们研究的目的是在波兰2型糖尿病患者中筛选脂联素基因外显子3的罕见突变,因为没有关于这些突变在我们人群中的频率和作用的数据。该研究在187名波兰2型糖尿病患者(32名女性,155名男性,平均年龄54.1±8.6岁)和102名年龄和性别匹配的健康对照组中进行。结果:脂联素基因3外显子突变频率为3.9%,对照组为0.98%,差异无统计学意义。我们还观察到c.331患者的脂联素水平明显较低T- >C突变(Y111H)与没有该突变的受试者相比(5.0 ug/ml vs 14.4 ug/ml, p=0.0148)。结论:据我们所知,目前的研究是第一个在波兰人口中表明这一点的研究。
{"title":"Single Nucleotide Polymorphisms in exon 3 of the adiponectin gene in subjects with type 2 diabetes mellitus.","authors":"A Kretowski,&nbsp;K Gugała,&nbsp;A Okruszko,&nbsp;N Wawrusiewicz-Kurylonek,&nbsp;M Górska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Adiponectin (APM1)--a newly discovered adipocytokine secreted by fat tissue--was recently suggested to play a role in the genetic predisposition to type 2 diabetes, obesity and insulin resistance. Adiponectin gene is localized on chromosome 3q27 within the region which was identified as susceptibility locus for type 2 diabetes and metabolic syndrome. Till now genetic associations of two SNP in exon 2 (+45T/G) and intron 2 (+276G/T) of adiponectin gene with type 2 diabetes and adiponectin level were reported in Japanese population and with insulin resistance in some Caucasian populations (Italy, Germany). Moreover, in the proximal promoter region of the APM1 gene: SNP-11426A/G and -11391A/-11377G haplotype predicted the associations with fasting plasma glucose, type 2 diabetes and adiponectin levels. On the other hand the role of mutations in exon 3 of the adiponectin gene is not so well studied.</p><p><strong>Material and methods: </strong>The aim of our study was the screening for rare mutation in exon 3 of adiponectin gene in the Polish subjects with type 2 diabetes as there is no data available about the frequency and role of these mutations in our population. The study was performed in the group of 187 Polish origin patients with type 2 diabetes (32 female and 155 male, mean age 54.1 +/- 8.6 yrs) and 102 age and sex matched healthy controls.</p><p><strong>Results: </strong>The frequency of adiponectin gene mutations in exon 3 was 3.9%, while in the control group 0.98% and this difference was not statistically significant. We also observed that adiponectin level is significantly lower in patients with c.331 T-->C mutation (Y111H) in comparison to subjects without this mutation (5.0 ug/ml vs 14.4 ug/ml, p=0.0148).</p><p><strong>Conclusions: </strong>To our knowledge the present study is the first which shows that in Polish populations.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"148-50"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thrombin activatable fibrinolysis inhibitor (TAFI) in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG). 凝血酶活化纤溶抑制剂(TAFI)在稳定型心绞痛患者行冠状动脉搭桥术(CABG)中的应用。
P Lisowski, J Małyszko, T Hirnle, A Lisowska, R Jackowski, J S Małyszko, L Buzun, M Myśliwiec

Purpose: Thrombin activatable fibrinolysis inhibitor (TAFI) seems to be a potential haemostatic risk factor of coronary artery disease (CAD). Taking into account interactions between TAFI and haemostasis, especially during cardiopulmonary bypass, we decided to determine concentration of TAFI and activated TAFI (TAFIa) and other haemostasis markers in CABG patients.

Material and methods: 45 CAD patients (11 women, 34 men) undergoing elective CABG were included in the study. Blood samples were taken before the operation, on the 3rd, 7th day and 3 months after CABG. A value of p<0.05 was considered statistically significant.

Results: We found a significant decrease in TAFIa concentration on 3rd postoperative day: 6 microg/ml (0.3-43.2) vs 8.9 microg/ml (0.5-37) before CABG (p<0.05), a significant increase in TAFI concentration on the 7th postoperative day: 127.7% +/- 36.8 vs 112.18% +/- 30.34 of standard plasma concentration before CABG (p<0.05), significant increase in plasmin-antyplasmin (PAP) complexes concentration on 3rd and 7th day, respectively: 645 microg/l (323-1237) vs 406 microg/l (197-1840) before CABG (p<0.001); and 1030 microg/l (640-2149) vs 406 microg/l (197-1840) before CABG (p<0.0001). Before operation we found a significant negative correlation between PAP complexes concentration before CABG and EuroSCORE risk scale value (p<0.01).

Conclusions: In CABG patients, there is a significant increase in fibrinolytic activity due to decrease in TAFIa concentration, with simultaneous increase in PAP complexes. A significant negative correlation between PAP complexes concentration before CABG and EuroSCORE risk scale value stressed a potentially higher operation risk in patients with lower fibrinolytic activity.

目的:凝血酶活化纤溶抑制剂(TAFI)似乎是冠状动脉疾病(CAD)的潜在止血危险因素。考虑到TAFI与止血之间的相互作用,特别是在体外循环期间,我们决定测定CABG患者中TAFI的浓度、激活TAFI (TAFIa)和其他止血标志物。材料和方法:45例冠心病患者(女性11例,男性34例)择期行冠脉搭桥。术前、术后第3天、第7天和第3个月取血。结果:我们发现术后第3天TAFIa浓度显著降低:6微克/毫升(0.3-43.2),而CABG前为8.9微克/毫升(0.5-37)。结论:CABG患者由于TAFIa浓度降低,纤溶活性显著增加,同时PAP复合物增加。CABG术前PAP复合物浓度与EuroSCORE风险量表值呈显著负相关,表明纤溶活性较低的患者可能存在较高的手术风险。
{"title":"Thrombin activatable fibrinolysis inhibitor (TAFI) in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG).","authors":"P Lisowski,&nbsp;J Małyszko,&nbsp;T Hirnle,&nbsp;A Lisowska,&nbsp;R Jackowski,&nbsp;J S Małyszko,&nbsp;L Buzun,&nbsp;M Myśliwiec","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Thrombin activatable fibrinolysis inhibitor (TAFI) seems to be a potential haemostatic risk factor of coronary artery disease (CAD). Taking into account interactions between TAFI and haemostasis, especially during cardiopulmonary bypass, we decided to determine concentration of TAFI and activated TAFI (TAFIa) and other haemostasis markers in CABG patients.</p><p><strong>Material and methods: </strong>45 CAD patients (11 women, 34 men) undergoing elective CABG were included in the study. Blood samples were taken before the operation, on the 3rd, 7th day and 3 months after CABG. A value of p<0.05 was considered statistically significant.</p><p><strong>Results: </strong>We found a significant decrease in TAFIa concentration on 3rd postoperative day: 6 microg/ml (0.3-43.2) vs 8.9 microg/ml (0.5-37) before CABG (p<0.05), a significant increase in TAFI concentration on the 7th postoperative day: 127.7% +/- 36.8 vs 112.18% +/- 30.34 of standard plasma concentration before CABG (p<0.05), significant increase in plasmin-antyplasmin (PAP) complexes concentration on 3rd and 7th day, respectively: 645 microg/l (323-1237) vs 406 microg/l (197-1840) before CABG (p<0.001); and 1030 microg/l (640-2149) vs 406 microg/l (197-1840) before CABG (p<0.0001). Before operation we found a significant negative correlation between PAP complexes concentration before CABG and EuroSCORE risk scale value (p<0.01).</p><p><strong>Conclusions: </strong>In CABG patients, there is a significant increase in fibrinolytic activity due to decrease in TAFIa concentration, with simultaneous increase in PAP complexes. A significant negative correlation between PAP complexes concentration before CABG and EuroSCORE risk scale value stressed a potentially higher operation risk in patients with lower fibrinolytic activity.</p>","PeriodicalId":79372,"journal":{"name":"Roczniki Akademii Medycznej w Bialymstoku (1995)","volume":"50 ","pages":"166-72"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25754748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Roczniki Akademii Medycznej w Bialymstoku (1995)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1